Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 10, 2009 - Issue 4-3
Submit an article Journal homepage
246
Views
31
CrossRef citations to date
0
Altmetric
Brief Reports

Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug

Chun-Rong Li Department of Psychiatry, Chonbuk National University Medical School & Institute for Medical Sciences, Jeonju, South Korea; Department of Psychiatry, Chonbuk National University Hospital & Research Institute of Clinical Medicine, Deokjin-gu, Jeonju, South Korea
,
Young-Chul Chung Department of Psychiatry, Chonbuk National University Medical School & Institute for Medical Sciences, Jeonju, South Korea; Department of Psychiatry, Chonbuk National University Hospital & Research Institute of Clinical Medicine, Deokjin-gu, Jeonju, South KoreaCorrespondence[email protected]
, PhD , MD,
Tae-Won Park Department of Psychiatry, Chonbuk National University Medical School & Institute for Medical Sciences, Jeonju, South Korea; Department of Psychiatry, Chonbuk National University Hospital & Research Institute of Clinical Medicine, Deokjin-gu, Jeonju, South Korea
,
Jong-Chul Yang Department of Psychiatry, Chonbuk National University Hospital & Research Institute of Clinical Medicine, Deokjin-gu, Jeonju, South Korea
,
Kee-Won Kim Department of Pharmacology, Chonbuk National University Medical School & Institute for Medical Sciences, Deokjin-gu, Jeonju, South Korea
,
Keon-Hak Lee Maemsarang Hospital, In-san Medical Foundation, Jeonju, South Korea
&
Ik-Keun Hwang Department of Psychiatry, Chonbuk National University Medical School & Institute for Medical Sciences, Jeonju, South Korea; Department of Psychiatry, Chonbuk National University Hospital & Research Institute of Clinical Medicine, Deokjin-gu, Jeonju, South Korea
 show all
Pages 919-924 | Received 05 Jun 2008, Published online: 08 Dec 2009

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Erum Shireen. (2016) Experimental treatment of antipsychotic-induced movement disorders. Journal of Experimental Pharmacology 8, pages 1-10.
Read now
Mesut Cetin. (2014) Clozaphobia: Fear of Prescribers of Clozapine for Treatment of Schizophrenia. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 24:4, pages 295-301.
Read now

Articles from other publishers (29)

Oliver Delgaram-Nejad, Dawn Archer, Gerasimos Chatzidamianos, Louise Robinson & Alex Bartha. (2023) The DAIS-C: A small, specialised, spoken, schizophrenia corpus. Applied Corpus Linguistics 3:3, pages 100069.
Crossref
Reyhaneh Rabiee, Saeedeh Hosseini Hooshiar, Amir Ghaderi & Sadegh Jafarnejad. (2022) Schizophrenia, Curcumin and Minimizing Side Effects of Antipsychotic Drugs: Possible Mechanisms. Neurochemical Research 48:3, pages 713-724.
Crossref
Qilin Liang, Dongmei Wang, Huixia Zhou, Dachun Chen, Meihong Xiu, Lixia Cui & Xiangyang Zhang. (2022) Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment. Journal of Psychiatric Research 151, pages 181-187.
Crossref
Sameer Jauhar, Mandy Johnstone & Peter J McKenna. (2022) Schizophrenia. The Lancet 399:10323, pages 473-486.
Crossref
Pichet Termsarasab & Steven J Frucht. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 3 17 .
Mahmut Selçuk. (2021) Tardive Myoclonus Responsive to Clozapine Misdiagnosed as Restless Leg Syndrome. Journal of Clinical Psychopharmacology 41:6, pages 692-694.
Crossref
Jia-Ying Shen, Nian-Sheng Tzeng, Chin-Bin Yeh & Tien-Yu Chen. (2021) Clozapine-Induced Reversible Pisa Syndrome in a Patient With Delusional Parasitosis. American Journal of Therapeutics Publish Ahead of Print.
Crossref
Stewart A. Factor. (2020) Management of Tardive Syndrome: Medications and Surgical Treatments. Neurotherapeutics 17:4, pages 1694-1712.
Crossref
Mei Huang, Wenqi He, Lakshmi Rajagopal, Andrea Kudwa, Dimitri E. Grigoriadis & Herbert Y. Meltzer. (2020) Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action. Pharmacology Biochemistry and Behavior 190, pages 172872.
Crossref
E. E. Vaiman, N. A. Shnayder, N. G. Neznanov & R. F. Nasyrova. (2019) Antipsychotic-induced tardive dyskinesia as a serious adverse effect in the psychopharmacotherapy of schizophrenia. Neurology, Neuropsychiatry, Psychosomatics 11:4, pages 4-13.
Crossref
Parnian Pardis, Gary Remington, Roshni Panda, Milan Lemez & Ofer Agid. (2019) Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review. Journal of Psychopharmacology 33:10, pages 1187-1198.
Crossref
Rikinkumar S. Patel, Zeeshan Mansuri & Amit Chopra. (2019) Analysis of risk factors and outcomes in psychiatric inpatients with tardive dyskinesia: A nationwide case-control study. Heliyon 5:5, pages e01745.
Crossref
Erin Feinstein & Ruth Walker. (2018) An Update on the Treatment of Chorea. Current Treatment Options in Neurology 20:10.
Crossref
Marco Solmi, Giorgio Pigato, John M. Kane & Christoph U. Correll. (2018) Clinical risk factors for the development of tardive dyskinesia. Journal of the Neurological Sciences 389, pages 21-27.
Crossref
Nicki Niemann & Joseph Jankovic. (2018) Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs 78:5, pages 525-541.
Crossref
Davide Amato, Anthony C. Vernon & Francesco Papaleo. (2018) Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability. Neuroscience & Biobehavioral Reviews 85, pages 146-159.
Crossref
Katharina Stegmayer, Sebastian Walther & Peter van Harten. (2018) Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies. CNS Drugs 32:2, pages 135-147.
Crossref
DINESH SANGROULA, INDERPREET VIRK, WALI MOHAMMAD & DAVID A. KAHN. (2017) Clozapine Treatment of Olanzapine-induced Tardive Dyskinesia: A Case Report. Journal of Psychiatric Practice 23:1, pages 53-59.
Crossref
Joshua Lister, Ana C. Andreazza, Bushra Navaid, Virginia S. Wilson, Celine Teo, Yasika Nesarajah, Alan A. Wilson, José N. Nobrega, Paul J. Fletcher & Gary Remington. (2017) Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 72, pages 23-29.
Crossref
Paul P. Lerner, Chanoch Miodownik & Vladimir Lerner. (2015) Tardive dyskinesia (syndrome): Current concept and modern approaches to its management. Psychiatry and Clinical Neurosciences 69:6, pages 321-334.
Crossref
Hiroshi Kimura, Nobuhisa Kanahara, Naoya Komatsu, Minoru Ishige, Katsumasa Muneoka, Masayuki Yoshimura, Hiroshi Yamanaka, Tomotaka Suzuki, Hideki Komatsu, Tsuyoshi Sasaki, Tasuku Hashimoto, Tadashi Hasegawa, Akihiro Shiina, Masatomo Ishikawa, Yoshimoto Sekine, Tetsuya Shiraishi, Hiroyuki Watanabe, Eiji Shimizu, Kenji Hashimoto & Masaomi Iyo. (2014) A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis. Schizophrenia Research 155:1-3, pages 52-58.
Crossref
Leslie J. Cloud, Deepti Zutshi & Stewart A. Factor. (2013) Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder. Neurotherapeutics 11:1, pages 166-176.
Crossref
Nandita Hazari, Natasha Kate & Sandeep Grover. (2013) Clozapine and tardive movement disorders: A review. Asian Journal of Psychiatry 6:6, pages 439-451.
Crossref
Masaomi Iyo, Shigenori Tadokoro, Nobuhisa Kanahara, Tasuku Hashimoto, Tomihisa Niitsu, Hiroyuki Watanabe & Kenji Hashimoto. (2013) Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis. Journal of Clinical Psychopharmacology 33:3, pages 398-404.
Crossref
Herbert Y. Meltzer. (2012) Clozapine. Clinical Schizophrenia & Related Psychoses 6:3, pages 134-144.
Crossref
Fan Wang, Hongzhen Fan, Hongqiang Sun, Fude Yang, Yixiao Luo, Haibo Liu, Thomas R. Kosten, Lin Lu & Xiang Yang Zhang. (2012) Association between TNF-α promoter −308A/G polymorphism and tardive dyskinesiain Chinese Han patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 37:1, pages 106-110.
Crossref
Y. Auxéméry. (2011) Dyskinésies tardives secondaires aux neuroleptiques et antipsychotiques : quelles perspectives thérapeutiques ?. Annales Médico-psychologiques, revue psychiatrique 169:8, pages 528-535.
Crossref
Gonzalo J. Revuelta, Leslie Cloud, Pratibha G. Aia & Stewart A. Factor. 2011. Hyperkinetic Movement Disorders. Hyperkinetic Movement Disorders 331 352 .
Peter N. van Harten & Diederik E. Tenback. 2011. Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia. Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia 187 210 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.